<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"><channel rdf:about="http://onlinelibrary.wiley.com/rss/journal/10.1002/(ISSN)1759-2887" xmlns="http://purl.org/rss/1.0/"><title>Research Synthesis Methods</title><description> Wiley Online Library : Research Synthesis Methods</description><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2F%28ISSN%291759-2887</link><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc</dc:publisher><dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">en</dc:language><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">© John Wiley &amp; Sons, Ltd.</dc:rights><prism:issn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1759-2879</prism:issn><prism:eIssn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1759-2887</prism:eIssn><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-01T00:00:00-05:00</dc:date><prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">March 2013</prism:coverDisplayDate><prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">4</prism:volume><prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1</prism:number><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">108</prism:endingPage><image rdf:resource="http://onlinelibrary.wiley.com/store/10.1002/jrsm.v4.1/asset/cover.gif?v=1&amp;s=9a48665510378edbc86356311abf55807ee3271f"/><items><rdf:Seq><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1079"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1076"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1075"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1070"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1073"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1067"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1063"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1066"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1065"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1068"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1056"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1064"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1062"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1074"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1078"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1077"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1061"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1060"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1071"/></rdf:Seq></items></channel><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1079" xmlns="http://purl.org/rss/1.0/"><title>Meta-analysis inside and outside particle physics: convergence using the path of least resistance?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1079</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Meta-analysis inside and outside particle physics: convergence using the path of least resistance?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Dan Jackson, Rose Baker</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-17T06:15:54.893924-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1079</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1079</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1079</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Method Note</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>In this note, we explain how the method proposed by Hartung and Knapp provides a compromise between conventional meta-analysis methodology and ‘unconstrained averaging’, as used by the Particle Data Group. Copyright © 2013 John Wiley &amp; Sons, Ltd.</p></div>]]></content:encoded><description>
In this note, we explain how the method proposed by Hartung and Knapp provides a compromise between conventional meta-analysis methodology and ‘unconstrained averaging’, as used by the Particle Data Group. Copyright © 2013 John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1076" xmlns="http://purl.org/rss/1.0/"><title>Less is less: a systematic review of graph use in meta-analyses</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1076</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Less is less: a systematic review of graph use in meta-analyses</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Anne H. E. Schild, Martin Voracek</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-22T01:13:12.931917-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1076</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1076</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1076</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Graphs are an essential part of scientific communication. Complex datasets, of which meta-analyses are textbook examples, benefit the most from visualization. Although a number of graph options for meta-analyses exist, the extent to which these are used was hitherto unclear. A systematic review on graph use in meta-analyses in three disciplines (medicine, psychology, and business) and nine journals was conducted. Interdisciplinary differences, which are mirrored in the respective journals, were revealed, that is, graph use correlates with external factors rather than methodological considerations. There was only limited variation in graph types (with forest plots as the most important representatives), and diagnostic plots were very rare. Although an increase in graph use over time could be observed, it is unlikely that this phenomenon is specific to meta-analyses. There is a gaping discrepancy between available graphic methods and their application in meta-analyses. This may be rooted in a number of factors, namely, (i) insufficient dissemination of new developments, (ii) unsatisfactory implementation in software packages, and (iii) minor attention on graphics in meta-analysis reporting guidelines. Using visualization methods to their full capacity is a further step in using meta-analysis to its full potential. Copyright © 2013 John Wiley &amp; Sons, Ltd.</p></div>]]></content:encoded><description>
Graphs are an essential part of scientific communication. Complex datasets, of which meta-analyses are textbook examples, benefit the most from visualization. Although a number of graph options for meta-analyses exist, the extent to which these are used was hitherto unclear. A systematic review on graph use in meta-analyses in three disciplines (medicine, psychology, and business) and nine journals was conducted. Interdisciplinary differences, which are mirrored in the respective journals, were revealed, that is, graph use correlates with external factors rather than methodological considerations. There was only limited variation in graph types (with forest plots as the most important representatives), and diagnostic plots were very rare. Although an increase in graph use over time could be observed, it is unlikely that this phenomenon is specific to meta-analyses. There is a gaping discrepancy between available graphic methods and their application in meta-analyses. This may be rooted in a number of factors, namely, (i) insufficient dissemination of new developments, (ii) unsatisfactory implementation in software packages, and (iii) minor attention on graphics in meta-analysis reporting guidelines. Using visualization methods to their full capacity is a further step in using meta-analysis to its full potential. Copyright © 2013 John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1075" xmlns="http://purl.org/rss/1.0/"><title>Bayesian meta-analysis of coefficient alpha</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1075</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Bayesian meta-analysis of coefficient alpha</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Michael T. Brannick, Nanhua Zhang</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-18T01:34:43.476706-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1075</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1075</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1075</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The current paper describes and illustrates a Bayesian approach to the meta-analysis of coefficient alpha. Alpha is the most commonly used estimate of the reliability or consistency (freedom from measurement error) for educational and psychological measures. The conventional approach to meta-analysis uses inverse variance weights to combine information from independent studies to provide an overall estimate. The Bayesian approach provides similar estimates to the conventional approach if a diffuse prior is used. However, the Bayesian approach also provides ‘shrunken’ local estimates of reliability in each context. The amount of shrinkage depends upon both the variability in the underlying populations and the sampling variance of the local estimates. Advantages of the approach are the estimation of individual studies adjusted for sampling error and the application of meta-analytic results to new local studies in which the local study ‘borrows strength’ from the meta-analysis. The ability to borrow strength for the new local studies is particularly useful in applied work in which the estimate of the local parameter is of primary interest. The approach is illustrated by the analysis of studies of the reliability of the General Ethnicity Questionnaire – Abridged, a measure of identification with the culture of one's heritage and the culture of one's host country. Copyright © 2013 John Wiley &amp; Sons, Ltd.</p></div>]]></content:encoded><description>
The current paper describes and illustrates a Bayesian approach to the meta-analysis of coefficient alpha. Alpha is the most commonly used estimate of the reliability or consistency (freedom from measurement error) for educational and psychological measures. The conventional approach to meta-analysis uses inverse variance weights to combine information from independent studies to provide an overall estimate. The Bayesian approach provides similar estimates to the conventional approach if a diffuse prior is used. However, the Bayesian approach also provides ‘shrunken’ local estimates of reliability in each context. The amount of shrinkage depends upon both the variability in the underlying populations and the sampling variance of the local estimates. Advantages of the approach are the estimation of individual studies adjusted for sampling error and the application of meta-analytic results to new local studies in which the local study ‘borrows strength’ from the meta-analysis. The ability to borrow strength for the new local studies is particularly useful in applied work in which the estimate of the local parameter is of primary interest. The approach is illustrated by the analysis of studies of the reliability of the General Ethnicity Questionnaire – Abridged, a measure of identification with the culture of one's heritage and the culture of one's host country. Copyright © 2013 John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1070" xmlns="http://purl.org/rss/1.0/"><title>Robust variance estimation in meta-regression with binary dependent effects</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1070</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Robust variance estimation in meta-regression with binary dependent effects</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Elizabeth Tipton</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-07T10:06:06.648863-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1070</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1070</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1070</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Dependent effect size estimates are a common problem in meta-analysis. Recently, a robust variance estimation method was introduced that can be used whenever effect sizes in a meta-analysis are not independent. This problem arises, for example, when effect sizes are nested or when multiple measures are collected on the same individuals. In this paper, we investigate the robustness of this method in small samples when the effect size of interest is the risk difference, log risk ratio, or log odds ratio. This simulation study examines the accuracy of 95% confidence intervals constructed using the robust variance estimator across a large variety of parameter values. We report results for both estimations of the mean effect (intercept) and of a slope. The results indicate that the robust variance estimator performs well even when the number of studies is as small as 10, although coverage is generally less than nominal in the slope estimation case. Throughout, an example based on a meta-analysis of cognitive behavior therapy is used for motivation. Copyright © 2013 John Wiley &amp; Sons, Ltd.</p></div>]]></content:encoded><description>
Dependent effect size estimates are a common problem in meta-analysis. Recently, a robust variance estimation method was introduced that can be used whenever effect sizes in a meta-analysis are not independent. This problem arises, for example, when effect sizes are nested or when multiple measures are collected on the same individuals. In this paper, we investigate the robustness of this method in small samples when the effect size of interest is the risk difference, log risk ratio, or log odds ratio. This simulation study examines the accuracy of 95% confidence intervals constructed using the robust variance estimator across a large variety of parameter values. We report results for both estimations of the mean effect (intercept) and of a slope. The results indicate that the robust variance estimator performs well even when the number of studies is as small as 10, although coverage is generally less than nominal in the slope estimation case. Throughout, an example based on a meta-analysis of cognitive behavior therapy is used for motivation. Copyright © 2013 John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1073" xmlns="http://purl.org/rss/1.0/"><title>Combining study outcome measures using dominance adjusted weights</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1073</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Combining study outcome measures using dominance adjusted weights</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kepher H. Makambi, Wenxin Lu</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-07T10:05:54.675137-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1073</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1073</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1073</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Weighting of studies in meta-analysis is usually implemented by using the estimated inverse variances of treatment effect estimates. However, there is a possibility of one study dominating other studies in the estimation process by taking on a weight that is above some upper limit. We implement an estimator of the heterogeneity variance that takes advantage of dominance adjusted weights. The performance of this estimator is compared with that of the commonly used estimator in meta-analysis, the DerSimonian–Laird estimator. Two test procedures for the overall treatment effect are proposed that are based on the quadratic form associated with the proposed heterogeneity variance estimator. An example is given to illustrate the application of these procedures. Copyright © 2013 John Wiley &amp; Sons, Ltd.</p></div>]]></content:encoded><description>
Weighting of studies in meta-analysis is usually implemented by using the estimated inverse variances of treatment effect estimates. However, there is a possibility of one study dominating other studies in the estimation process by taking on a weight that is above some upper limit. We implement an estimator of the heterogeneity variance that takes advantage of dominance adjusted weights. The performance of this estimator is compared with that of the commonly used estimator in meta-analysis, the DerSimonian–Laird estimator. Two test procedures for the overall treatment effect are proposed that are based on the quadratic form associated with the proposed heterogeneity variance estimator. An example is given to illustrate the application of these procedures. Copyright © 2013 John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1067" xmlns="http://purl.org/rss/1.0/"><title>Random-effects meta-analysis of time-to-event data using the expectation–maximisation algorithm and shrinkage estimators</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1067</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Random-effects meta-analysis of time-to-event data using the expectation–maximisation algorithm and shrinkage estimators</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mark C Simmonds, Julian PT Higgins, Lesley A Stewart</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-11-22T11:11:09.327368-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1067</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1067</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1067</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Meta-analysis of time-to-event data has proved difficult in the past because consistent summary statistics often cannot be extracted from published results. The use of individual patient data allows for the re-analysis of each study in a consistent fashion and thus makes meta-analysis of time-to-event data feasible. Time-to-event data can be analysed using proportional hazards models, but incorporating random effects into these models is not straightforward in standard software.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This paper fits random-effects proportional hazards models by treating the random effects as missing data and applying the expectation–maximisation algorithm. This approach has been used before by using Markov chain Monte Carlo methods to perform the expectation step of the algorithm. In this paper, the expectation step is simplified, without sacrificing accuracy, by approximating the expected values of the random effects using simple shrinkage estimators. This provides a robust method for fitting random-effects models that can be implemented in standard statistical packages. Copyright © 2012 John Wiley &amp; Sons, Ltd.</p></div>]]></content:encoded><description>
Meta-analysis of time-to-event data has proved difficult in the past because consistent summary statistics often cannot be extracted from published results. The use of individual patient data allows for the re-analysis of each study in a consistent fashion and thus makes meta-analysis of time-to-event data feasible. Time-to-event data can be analysed using proportional hazards models, but incorporating random effects into these models is not straightforward in standard software.
This paper fits random-effects proportional hazards models by treating the random effects as missing data and applying the expectation–maximisation algorithm. This approach has been used before by using Markov chain Monte Carlo methods to perform the expectation step of the algorithm. In this paper, the expectation step is simplified, without sacrificing accuracy, by approximating the expected values of the random effects using simple shrinkage estimators. This provides a robust method for fitting random-effects models that can be implemented in standard statistical packages. Copyright © 2012 John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1063" xmlns="http://purl.org/rss/1.0/"><title>Synthesizing regression results: a factored likelihood method</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1063</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Synthesizing regression results: a factored likelihood method</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Meng-Jia Wu, Betsy Jane Becker</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-11-21T10:38:28.502491-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1063</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1063</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1063</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Regression methods are widely used by researchers in many fields, yet methods for synthesizing regression results are scarce. This study proposes using a factored likelihood method, originally developed to handle missing data, to appropriately synthesize regression models involving different predictors. This method uses the correlations reported in the regression studies to calculate synthesized standardized slopes. It uses available correlations to estimate missing ones through a series of regressions, allowing us to synthesize correlations among variables as if each included study contained all the same variables. Great accuracy and stability of this method under fixed-effects models were found through Monte Carlo simulation. An example was provided to demonstrate the steps for calculating the synthesized slopes through sweep operators. By rearranging the predictors in the included regression models or omitting a relatively small number of correlations from those models, we can easily apply the factored likelihood method to many situations involving synthesis of linear models. Limitations and other possible methods for synthesizing more complicated models are discussed. Copyright © 2012 John Wiley &amp; Sons, Ltd.</p></div>]]></content:encoded><description>
Regression methods are widely used by researchers in many fields, yet methods for synthesizing regression results are scarce. This study proposes using a factored likelihood method, originally developed to handle missing data, to appropriately synthesize regression models involving different predictors. This method uses the correlations reported in the regression studies to calculate synthesized standardized slopes. It uses available correlations to estimate missing ones through a series of regressions, allowing us to synthesize correlations among variables as if each included study contained all the same variables. Great accuracy and stability of this method under fixed-effects models were found through Monte Carlo simulation. An example was provided to demonstrate the steps for calculating the synthesized slopes through sweep operators. By rearranging the predictors in the included regression models or omitting a relatively small number of correlations from those models, we can easily apply the factored likelihood method to many situations involving synthesis of linear models. Limitations and other possible methods for synthesizing more complicated models are discussed. Copyright © 2012 John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1066" xmlns="http://purl.org/rss/1.0/"><title>Using meta-analysis to inform the design of subsequent studies of diagnostic test accuracy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1066</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Using meta-analysis to inform the design of subsequent studies of diagnostic test accuracy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sally R. Hinchliffe, Michael J. Crowther, Robert S. Phillips, Alex J. Sutton</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-11-21T05:48:12.898714-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1066</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1066</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1066</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>An individual diagnostic accuracy study rarely provides enough information to make conclusive recommendations about the accuracy of a diagnostic test; particularly when the study is small. Meta-analysis methods provide a way of combining information from multiple studies, reducing uncertainty in the result and hopefully providing substantial evidence to underpin reliable clinical decision-making. Very few investigators consider any sample size calculations when designing a new diagnostic accuracy study. However, it is important to consider the number of subjects in a new study in order to achieve a precise measure of accuracy.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Sutton <em>et al</em>. have suggested previously that when designing a new therapeutic trial, it could be more beneficial to consider the power of the updated meta-analysis including the new trial rather than of the new trial itself. The methodology involves simulating new studies for a range of sample sizes and estimating the power of the updated meta-analysis with each new study added. Plotting the power values against the range of sample sizes allows the clinician to make an informed decision about the sample size of a new trial. This paper extends this approach from the trial setting and applies it to diagnostic accuracy studies. Several meta-analytic models are considered including bivariate random effects meta-analysis that models the correlation between sensitivity and specificity. Copyright © 2012 John Wiley &amp; Sons, Ltd.</p></div>]]></content:encoded><description>
An individual diagnostic accuracy study rarely provides enough information to make conclusive recommendations about the accuracy of a diagnostic test; particularly when the study is small. Meta-analysis methods provide a way of combining information from multiple studies, reducing uncertainty in the result and hopefully providing substantial evidence to underpin reliable clinical decision-making. Very few investigators consider any sample size calculations when designing a new diagnostic accuracy study. However, it is important to consider the number of subjects in a new study in order to achieve a precise measure of accuracy.
Sutton et al. have suggested previously that when designing a new therapeutic trial, it could be more beneficial to consider the power of the updated meta-analysis including the new trial rather than of the new trial itself. The methodology involves simulating new studies for a range of sample sizes and estimating the power of the updated meta-analysis with each new study added. Plotting the power values against the range of sample sizes allows the clinician to make an informed decision about the sample size of a new trial. This paper extends this approach from the trial setting and applies it to diagnostic accuracy studies. Several meta-analytic models are considered including bivariate random effects meta-analysis that models the correlation between sensitivity and specificity. Copyright © 2012 John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1065" xmlns="http://purl.org/rss/1.0/"><title>Meta-analysis inside and outside particle physics: two traditions that should converge?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1065</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Meta-analysis inside and outside particle physics: two traditions that should converge?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rose D. Baker, Dan Jackson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-11-06T04:03:01.223768-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1065</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1065</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1065</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The use of meta-analysis in medicine and epidemiology really took off in the 1970s. However, in high-energy physics, the Particle Data Group has been carrying out meta-analyses of measurements of particle masses and other properties since 1957. Curiously, there has been virtually no interaction between those working inside and outside particle physics. In this paper, we use statistical models to study two major differences in practice. The first is the usefulness of systematic errors, which physicists are now beginning to quote in addition to statistical errors. The second is whether it is better to treat heterogeneity by scaling up errors as do the Particle Data Group or by adding a random effect as does the rest of the community. Besides fitting models, we derive and use an exact test of the error-scaling hypothesis. We also discuss the other methodological differences between the two streams of meta-analysis. Our conclusion is that systematic errors are not currently very useful and that the conventional random effects model, as routinely used in meta-analysis, has a useful role to play in particle physics. The moral we draw for statisticians is that we should be more willing to explore ‘grassroots’ areas of statistical application, so that good statistical practice can flow both from and back to the statistical mainstream. Copyright © 2012 John Wiley &amp; Sons, Ltd.</p></div>]]></content:encoded><description>
The use of meta-analysis in medicine and epidemiology really took off in the 1970s. However, in high-energy physics, the Particle Data Group has been carrying out meta-analyses of measurements of particle masses and other properties since 1957. Curiously, there has been virtually no interaction between those working inside and outside particle physics. In this paper, we use statistical models to study two major differences in practice. The first is the usefulness of systematic errors, which physicists are now beginning to quote in addition to statistical errors. The second is whether it is better to treat heterogeneity by scaling up errors as do the Particle Data Group or by adding a random effect as does the rest of the community. Besides fitting models, we derive and use an exact test of the error-scaling hypothesis. We also discuss the other methodological differences between the two streams of meta-analysis. Our conclusion is that systematic errors are not currently very useful and that the conventional random effects model, as routinely used in meta-analysis, has a useful role to play in particle physics. The moral we draw for statisticians is that we should be more willing to explore ‘grassroots’ areas of statistical application, so that good statistical practice can flow both from and back to the statistical mainstream. Copyright © 2012 John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1068" xmlns="http://purl.org/rss/1.0/"><title>An introduction to methodological issues when including non-randomised studies in systematic reviews on the effects of interventions</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1068</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">An introduction to methodological issues when including non-randomised studies in systematic reviews on the effects of interventions</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Barnaby C. Reeves, Julian P. T. Higgins, Craig Ramsay, Beverley Shea, Peter Tugwell, George A. Wells</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-24T05:55:31.312687-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1068</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1068</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1068</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Special Issue Paper</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">11</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="section" id="jrsm1068-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h4>Background</h4><div class="para"><p>Methods need to be further developed to include non-randomised studies (NRS) in systematic reviews of the effects of health care interventions. NRS are often required to answer questions about harms and interventions for which evidence from randomised controlled trials (RCTs) is not available. Methods used to review randomised controlled trials may be inappropriate or insufficient for NRS.</p></div></div>
<div class="section" id="jrsm1068-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Aim and methods</h4><div class="para"><p>A workshop was convened to discuss relevant methodological issues. Participants were invited from important stakeholder constituencies, including methods and review groups of the Cochrane and Campbell Collaborations, the Cochrane Editorial Unit and organisations that commission reviews and make health policy decisions. The aim was to discuss methods for reviewing evidence when including NRS and to formulate methodological guidance for review authors.</p></div></div>
<div class="section" id="jrsm1068-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Workshop format</h4><div class="para"><p>The workshop was structured around four sessions on topics considered in advance to be most critical: (i) study designs and bias; (ii) confounding and meta-analysis; (iii) selective reporting; and (iv) applicability. These sessions were scheduled between introductory and concluding sessions.</p></div></div>
<div class="section" id="jrsm1068-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Summary</h4><div class="para"><p>This is the first of six papers and provides an overview. Subsequent papers describe the discussions and conclusions from the four main sessions (papers 2 to 5) and summarise the proposed guidance into lists of issues for review authors to consider (paper 6). Copyright © 2013 John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>

Background
Methods need to be further developed to include non-randomised studies (NRS) in systematic reviews of the effects of health care interventions. NRS are often required to answer questions about harms and interventions for which evidence from randomised controlled trials (RCTs) is not available. Methods used to review randomised controlled trials may be inappropriate or insufficient for NRS.

Aim and methods
A workshop was convened to discuss relevant methodological issues. Participants were invited from important stakeholder constituencies, including methods and review groups of the Cochrane and Campbell Collaborations, the Cochrane Editorial Unit and organisations that commission reviews and make health policy decisions. The aim was to discuss methods for reviewing evidence when including NRS and to formulate methodological guidance for review authors.

Workshop format
The workshop was structured around four sessions on topics considered in advance to be most critical: (i) study designs and bias; (ii) confounding and meta-analysis; (iii) selective reporting; and (iv) applicability. These sessions were scheduled between introductory and concluding sessions.

Summary
This is the first of six papers and provides an overview. Subsequent papers describe the discussions and conclusions from the four main sessions (papers 2 to 5) and summarise the proposed guidance into lists of issues for review authors to consider (paper 6). Copyright © 2013 John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1056" xmlns="http://purl.org/rss/1.0/"><title>Issues relating to study design and risk of bias when including non-randomized studies in systematic reviews on the effects of interventions</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1056</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Issues relating to study design and risk of bias when including non-randomized studies in systematic reviews on the effects of interventions</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Julian PT Higgins, Craig Ramsay, Barnaby C Reeves, Jonathan J Deeks, Beverley Shea, Jeffrey C Valentine, Peter Tugwell, George Wells</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-09-25T05:35:26.792991-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1056</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1056</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1056</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Special Issue Paper</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">25</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Non-randomized studies may provide valuable evidence on the effects of interventions. They are the main source of evidence on the intended effects of some types of interventions and often provide the only evidence about the effects of interventions on long-term outcomes, rare events or adverse effects. Therefore, systematic reviews on the effects of interventions may include various types of non-randomized studies. In this second paper in a series, we address how review authors might articulate the particular non-randomized study designs they will include and how they might evaluate, in general terms, the extent to which a particular non-randomized study is at risk of important biases. We offer guidance for describing and classifying different non-randomized designs based on specific features of the studies in place of using non-informative study design labels. We also suggest criteria to consider when deciding whether to include non-randomized studies. We conclude that a taxonomy of study designs based on study design features is needed. Review authors need new tools specifically to assess the risk of bias for some non-randomized designs that involve a different inferential logic compared with parallel group trials. Copyright © 2012 John Wiley &amp; Sons, Ltd.</p></div>]]></content:encoded><description>
Non-randomized studies may provide valuable evidence on the effects of interventions. They are the main source of evidence on the intended effects of some types of interventions and often provide the only evidence about the effects of interventions on long-term outcomes, rare events or adverse effects. Therefore, systematic reviews on the effects of interventions may include various types of non-randomized studies. In this second paper in a series, we address how review authors might articulate the particular non-randomized study designs they will include and how they might evaluate, in general terms, the extent to which a particular non-randomized study is at risk of important biases. We offer guidance for describing and classifying different non-randomized designs based on specific features of the studies in place of using non-informative study design labels. We also suggest criteria to consider when deciding whether to include non-randomized studies. We conclude that a taxonomy of study designs based on study design features is needed. Review authors need new tools specifically to assess the risk of bias for some non-randomized designs that involve a different inferential logic compared with parallel group trials. Copyright © 2012 John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1064" xmlns="http://purl.org/rss/1.0/"><title>Issues relating to confounding and meta-analysis when including non-randomized studies in systematic reviews on the effects of interventions</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1064</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Issues relating to confounding and meta-analysis when including non-randomized studies in systematic reviews on the effects of interventions</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jeffrey C. Valentine, Simon G. Thompson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-11-06T22:13:51.655106-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1064</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1064</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1064</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Special Issue Paper</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">26</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">35</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="section" id="jrsm1064-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h4>Background</h4><div class="para"><p>Confounding caused by selection bias is often a key difference between non-randomized studies (NRS) and randomized controlled trials (RCTs) of interventions.</p></div></div>
<div class="section" id="jrsm1064-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Key methodological issues</h4><div class="para"><p>In this third paper of the series, we consider issues relating to the inclusion of NRS in systematic reviews on the effects of interventions. We discuss whether potential biases from confounding in NRS can be accounted for, the limitations of current methods for attempting to do so, the different contexts of NRS and RCTs, the problems these issues create for reviewers, and a research agenda for the future.</p></div></div>
<div class="section" id="jrsm1064-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Guidance</h4><div class="para"><p>Reviewers who are considering whether or not to include NRS in meta-analyses must weigh a number of factors. Including NRS may allow a review to address outcomes or pragmatic implementations of an intervention not studied in RCTs, but it will also increase the workload for the review team, as well as their required technical repertoire. Furthermore, the results of a synthesis involving NRS will likely be more difficult to interpret, and less certain, relative to the results of a synthesis involving only randomized studies. When both randomized and non-randomized evidence are available, we favor a strategy of including NRS and RCTs in the same systematic review but synthesizing their results separately.</p></div></div>
<div class="section" id="jrsm1064-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusion</h4><div class="para"><p>Including NRS will often make the limitations of the evidence derived from RCTs more apparent, thereby guiding inferences about generalizability, and may help with the design of the next generation of RCTs. Copyright © 2012 John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>

Background
Confounding caused by selection bias is often a key difference between non-randomized studies (NRS) and randomized controlled trials (RCTs) of interventions.

Key methodological issues
In this third paper of the series, we consider issues relating to the inclusion of NRS in systematic reviews on the effects of interventions. We discuss whether potential biases from confounding in NRS can be accounted for, the limitations of current methods for attempting to do so, the different contexts of NRS and RCTs, the problems these issues create for reviewers, and a research agenda for the future.

Guidance
Reviewers who are considering whether or not to include NRS in meta-analyses must weigh a number of factors. Including NRS may allow a review to address outcomes or pragmatic implementations of an intervention not studied in RCTs, but it will also increase the workload for the review team, as well as their required technical repertoire. Furthermore, the results of a synthesis involving NRS will likely be more difficult to interpret, and less certain, relative to the results of a synthesis involving only randomized studies. When both randomized and non-randomized evidence are available, we favor a strategy of including NRS and RCTs in the same systematic review but synthesizing their results separately.

Conclusion
Including NRS will often make the limitations of the evidence derived from RCTs more apparent, thereby guiding inferences about generalizability, and may help with the design of the next generation of RCTs. Copyright © 2012 John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1062" xmlns="http://purl.org/rss/1.0/"><title>Issues relating to selective reporting when including non-randomized studies in systematic reviews on the effects of healthcare interventions</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1062</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Issues relating to selective reporting when including non-randomized studies in systematic reviews on the effects of healthcare interventions</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Susan L Norris, David Moher, Barnaby C Reeves, Beverley Shea, Yoon Loke, Sarah Garner, Laurie Anderson, Peter Tugwell, George Wells</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-11-13T02:54:39.740317-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1062</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1062</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1062</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Special Issue Paper</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">36</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">47</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="section" id="jrsm1062-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h4>Background</h4><div class="para"><p>Selective outcome and analysis reporting (SOR and SAR) occur when only a subset of outcomes measured and analyzed in a study is fully reported, and are an important source of potential bias.</p></div></div>
<div class="section" id="jrsm1062-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Key methodological issues</h4><div class="para"><p>We describe what is known about the prevalence and effects of SOR and SAR in both randomized controlled trials (RCTs) and non-randomized studies (NRS), and the effects of SOR and SAR on summary effect estimates and conclusions in systematic reviews of the effectiveness of healthcare interventions.</p></div></div>
<div class="section" id="jrsm1062-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Guidance</h4><div class="para"><p>Review authors should always suspect SOR and SAR in reviews that include NRS, assess primary studies for the risk of bias, and make reasonable attempts to retrieve study protocols or other documentation developed before study recruitment began. There are clues that may suggest SOR or SAR in NRS, including differences between the methods and results sections of the publication, study funder, and differences between study protocol or registration information and the study report.</p></div></div>
<div class="section" id="jrsm1062-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusion</h4><div class="para"><p>Existing evidence about reporting biases in primary studies comes almost exclusively from methodological reviews of RCTs. The prevalence and impact of SOR and SAR in NRS are likely even greater than in RCTs but it is difficult to identify and confirm selective reporting in NRS. Copyright © 2012 John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>

Background
Selective outcome and analysis reporting (SOR and SAR) occur when only a subset of outcomes measured and analyzed in a study is fully reported, and are an important source of potential bias.

Key methodological issues
We describe what is known about the prevalence and effects of SOR and SAR in both randomized controlled trials (RCTs) and non-randomized studies (NRS), and the effects of SOR and SAR on summary effect estimates and conclusions in systematic reviews of the effectiveness of healthcare interventions.

Guidance
Review authors should always suspect SOR and SAR in reviews that include NRS, assess primary studies for the risk of bias, and make reasonable attempts to retrieve study protocols or other documentation developed before study recruitment began. There are clues that may suggest SOR or SAR in NRS, including differences between the methods and results sections of the publication, study funder, and differences between study protocol or registration information and the study report.

Conclusion
Existing evidence about reporting biases in primary studies comes almost exclusively from methodological reviews of RCTs. The prevalence and impact of SOR and SAR in NRS are likely even greater than in RCTs but it is difficult to identify and confirm selective reporting in NRS. Copyright © 2012 John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1074" xmlns="http://purl.org/rss/1.0/"><title>Issues relating to selective reporting when including non-randomized studies in systematic reviews on the effects of healthcare interventions</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1074</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Issues relating to selective reporting when including non-randomized studies in systematic reviews on the effects of healthcare interventions</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Susan L Norris, David Moher, Barnaby C Reeves, Beverley Shea, Yoon Loke, Sarah Garner, Laurie Anderson, Peter Tugwell, George Wells</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-14T05:25:24.421376-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1074</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1074</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1074</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Erratum</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">48</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">48</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1078" xmlns="http://purl.org/rss/1.0/"><title>Non-randomized studies as a source of complementary, sequential or replacement evidence for randomized controlled trials in systematic reviews on the effects of interventions</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1078</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Non-randomized studies as a source of complementary, sequential or replacement evidence for randomized controlled trials in systematic reviews on the effects of interventions</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Holger J. Schünemann, Peter Tugwell, Barnaby C. Reeves, Elie A. Akl, Nancy Santesso, Frederick A. Spencer, Beverley Shea, George Wells, Mark Helfand</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-22T06:34:08.701112-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1078</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1078</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1078</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Special Issue Paper</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">49</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">62</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The terms applicability, generalizability, external validity and transferability are related, sometimes used interchangeably and have in common that they lack a clear and consistent definition in the classic epidemiological literature. However, all of these terms generally describe one overarching theme: whether or not available research evidence can be directly utilized to answer the healthcare questions at hand, ideally supported by a judgment about the degree of confidence for this utilization. This concept has been called directness. The objectives of this paper were to delineate how non-randomized studies (NRS) inform judgments in relation to directness and the concepts that it encompasses in the context of systematic reviews. We will briefly review what is known and describe the theoretical and practical issues as well as offer guidance to those tackling the challenges of judging directness and using research evidence to answer healthcare questions with evidence from NRS.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>In particular, we suggest a framework in which authors can use NRS as a complement, sequence or replacement for randomized controlled trials (RCTs) by focusing on judgments about the population, intervention, comparison and outcomes. Authors of systematic reviews will use NRS to complement judgments about the inconsistencies, the rationale and credibility of subgroup analysis, the baseline risk estimates for the determination of absolute benefits and downsides, and the directness of surrogate outcomes. This evidence includes contextual or supplementary evidence. Authors of systematic review and other summaries of the evidence use NRS as sequential evidence to provide evidence when insufficient evidence is available for an outcome from RCTs, but NRS evidence is available (e.g., long-term harms). Use of evidence from NRS may also serve to replace RCT evidence when NRS provide equivalent (or potentially higher) confidence in the evidence (i.e. quality) compared to indirect evidence from RCTs. These judgments will be made in the context of other domains that influence the overall quality of the body of evidence, including the risk of bias, publication bias (i.e. limitations in the detailed study design and execution), inconsistency, imprecision and factors that increase our confidence in effects.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This article will support systematic reviewers in their interaction with decision makers, that is, those who use the systematic review to develop guidelines, address health policy makers, and make clinical decisions, by making these judgments transparent. Copyright © 2013 John Wiley &amp; Sons, Ltd.</p></div>]]></content:encoded><description>
The terms applicability, generalizability, external validity and transferability are related, sometimes used interchangeably and have in common that they lack a clear and consistent definition in the classic epidemiological literature. However, all of these terms generally describe one overarching theme: whether or not available research evidence can be directly utilized to answer the healthcare questions at hand, ideally supported by a judgment about the degree of confidence for this utilization. This concept has been called directness. The objectives of this paper were to delineate how non-randomized studies (NRS) inform judgments in relation to directness and the concepts that it encompasses in the context of systematic reviews. We will briefly review what is known and describe the theoretical and practical issues as well as offer guidance to those tackling the challenges of judging directness and using research evidence to answer healthcare questions with evidence from NRS.
In particular, we suggest a framework in which authors can use NRS as a complement, sequence or replacement for randomized controlled trials (RCTs) by focusing on judgments about the population, intervention, comparison and outcomes. Authors of systematic reviews will use NRS to complement judgments about the inconsistencies, the rationale and credibility of subgroup analysis, the baseline risk estimates for the determination of absolute benefits and downsides, and the directness of surrogate outcomes. This evidence includes contextual or supplementary evidence. Authors of systematic review and other summaries of the evidence use NRS as sequential evidence to provide evidence when insufficient evidence is available for an outcome from RCTs, but NRS evidence is available (e.g., long-term harms). Use of evidence from NRS may also serve to replace RCT evidence when NRS provide equivalent (or potentially higher) confidence in the evidence (i.e. quality) compared to indirect evidence from RCTs. These judgments will be made in the context of other domains that influence the overall quality of the body of evidence, including the risk of bias, publication bias (i.e. limitations in the detailed study design and execution), inconsistency, imprecision and factors that increase our confidence in effects.
This article will support systematic reviewers in their interaction with decision makers, that is, those who use the systematic review to develop guidelines, address health policy makers, and make clinical decisions, by making these judgments transparent. Copyright © 2013 John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1077" xmlns="http://purl.org/rss/1.0/"><title>Checklists of methodological issues for review authors to consider when including non-randomized studies in systematic reviews</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1077</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Checklists of methodological issues for review authors to consider when including non-randomized studies in systematic reviews</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">George A Wells, Beverley Shea, Julian PT Higgins, Jonathan Sterne, Peter Tugwell, Barnaby C Reeves</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-22T06:34:08.701112-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1077</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1077</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1077</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Special Issue Paper</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">63</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">77</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="section" id="jrsm1077-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h4>Background</h4><div class="para"><p>There is increasing interest from review authors about including non-randomized studies (NRS) in their systematic reviews of health care interventions. This series from the Ottawa Non-Randomized Studies Workshop consists of six papers identifying methodological issues when doing this.</p></div></div>
<div class="section" id="jrsm1077-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Aim</h4><div class="para"><p>To format the guidance from the preceding papers on study design and bias, confounding and meta-analysis, selective reporting, and applicability/directness into checklists of issues for review authors to consider when including NRS in a systematic review.</p></div></div>
<div class="section" id="jrsm1077-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Checklists</h4><div class="para"><p>Checklists were devised providing frameworks to describe/assess: (1) study designs based on study design features; (2) risk of residual confounding and when to consider meta-analysing data from NRS; (3) risk of selective reporting based on the Cochrane framework for detecting selective outcome reporting in trials but extended to selective reporting of analyses; and (4) directness of evidence contributed by a study to aid integration of NRS findings into summary of findings tables.</p></div></div>
<div class="section" id="jrsm1077-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Summary</h4><div class="para"><p>The checklists described will allow review groups to operationalize the inclusion of NRS in systematic reviews in a more consistent way. The next major step is extending the existing Cochrane Risk of Bias tool so that it can assess the risk of bias to NRS included in a review. Copyright © 2013 John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>

Background
There is increasing interest from review authors about including non-randomized studies (NRS) in their systematic reviews of health care interventions. This series from the Ottawa Non-Randomized Studies Workshop consists of six papers identifying methodological issues when doing this.

Aim
To format the guidance from the preceding papers on study design and bias, confounding and meta-analysis, selective reporting, and applicability/directness into checklists of issues for review authors to consider when including NRS in a systematic review.

Checklists
Checklists were devised providing frameworks to describe/assess: (1) study designs based on study design features; (2) risk of residual confounding and when to consider meta-analysing data from NRS; (3) risk of selective reporting based on the Cochrane framework for detecting selective outcome reporting in trials but extended to selective reporting of analyses; and (4) directness of evidence contributed by a study to aid integration of NRS findings into summary of findings tables.

Summary
The checklists described will allow review groups to operationalize the inclusion of NRS in systematic reviews in a more consistent way. The next major step is extending the existing Cochrane Risk of Bias tool so that it can assess the risk of bias to NRS included in a review. Copyright © 2013 John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1061" xmlns="http://purl.org/rss/1.0/"><title>Reconstructing 2 x 2 contingency tables from odds ratios using the Di Pietrantonj method: difficulties, constraints and impact in meta-analysis results</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1061</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Reconstructing 2 x 2 contingency tables from odds ratios using the Di Pietrantonj method: difficulties, constraints and impact in meta-analysis results</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Areti Angeliki Veroniki, Marios Pavlides, Nikolaos A Patsopoulos, Georgia Salanti</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-11-12T06:58:03.154085-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1061</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1061</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1061</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">78</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">94</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>A problem that is frequently encountered during the systematic review process is when studies that meet the inclusion criteria do not provide the appropriate numerical estimates to include in a meta-analysis. For dichotomous outcomes, a method has been suggested by Di Pietrantonj for reconstructing the 2 × 2 table when the Odds Ratio (<em>OR</em>), the Standard Error (<em>SE</em>(<em>lnOR</em>)) and the sample sizes are provided. The method produces two possible 2 × 2 tables; and to select the correct one, the Control Group Risk (<em>CGR</em>) is used. As <em>CGR</em> is typically unknown and only rounded figures of the <em>OR</em> and <em>SE</em>(<em>lnOR</em>) are provided, the accuracy of the reconstruction method varies. In this paper, we evaluate the performance of the method using simulated and empirical data. Small studies with large <em>OR</em> and <em>CGR</em> away from 50% are reconstructed satisfactorily, and the use of <em>SE</em>(<em>lnOR</em>) rounded to the third decimal rather than the second one improves the performance of the method. However, when <em>CGR</em> is unknown, its estimation from other studies is problematic as it exhibits high heterogeneity. Inclusion of an incorrectly reconstructed table in the meta-analysis may result in different summary effects. Reviewers that consider applying the method should be cautious about its impact in the meta-analysis. Copyright © 2012 John Wiley &amp; Sons, Ltd.</p></div>]]></content:encoded><description>
A problem that is frequently encountered during the systematic review process is when studies that meet the inclusion criteria do not provide the appropriate numerical estimates to include in a meta-analysis. For dichotomous outcomes, a method has been suggested by Di Pietrantonj for reconstructing the 2 × 2 table when the Odds Ratio (OR), the Standard Error (SE(lnOR)) and the sample sizes are provided. The method produces two possible 2 × 2 tables; and to select the correct one, the Control Group Risk (CGR) is used. As CGR is typically unknown and only rounded figures of the OR and SE(lnOR) are provided, the accuracy of the reconstruction method varies. In this paper, we evaluate the performance of the method using simulated and empirical data. Small studies with large OR and CGR away from 50% are reconstructed satisfactorily, and the use of SE(lnOR) rounded to the third decimal rather than the second one improves the performance of the method. However, when CGR is unknown, its estimation from other studies is problematic as it exhibits high heterogeneity. Inclusion of an incorrectly reconstructed table in the meta-analysis may result in different summary effects. Reviewers that consider applying the method should be cautious about its impact in the meta-analysis. Copyright © 2012 John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1060" xmlns="http://purl.org/rss/1.0/"><title>The effect direction plot: visual display of non-standardised effects across multiple outcome domains</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1060</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The effect direction plot: visual display of non-standardised effects across multiple outcome domains</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hilary J Thomson, Sian Thomas</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-10-12T00:54:00.102785-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1060</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1060</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1060</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Method Note</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">95</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">101</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Visual display of reported impacts is a valuable aid to both reviewers and readers of systematic reviews. Forest plots are routinely prepared to report standardised effect sizes, but where standardised effect sizes are not available for all included studies a forest plot may misrepresent the available evidence. Tabulated data summaries to accompany the narrative synthesis can be lengthy and inaccessible. Moreover, the link between the data and the synthesis conclusions may be opaque.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This paper details the preparation of visual summaries of effect direction for multiple outcomes across 29 quantitative studies of the health impacts of housing improvement. A one page summary of reported health outcomes was prepared to accompany a 10 000-word narrative synthesis. The one page summary included details of study design, internal validity, sample size, time of follow-up, as well as changes in intermediate outcomes, for example, housing condition. This approach to visually summarising complex data can aid the reviewer in cross-study analysis and improve accessibility and transparency of the narrative synthesis where standardised effect sizes are not available. Copyright © 2012 John Wiley &amp; Sons, Ltd.</p></div>]]></content:encoded><description>
Visual display of reported impacts is a valuable aid to both reviewers and readers of systematic reviews. Forest plots are routinely prepared to report standardised effect sizes, but where standardised effect sizes are not available for all included studies a forest plot may misrepresent the available evidence. Tabulated data summaries to accompany the narrative synthesis can be lengthy and inaccessible. Moreover, the link between the data and the synthesis conclusions may be opaque.
This paper details the preparation of visual summaries of effect direction for multiple outcomes across 29 quantitative studies of the health impacts of housing improvement. A one page summary of reported health outcomes was prepared to accompany a 10 000-word narrative synthesis. The one page summary included details of study design, internal validity, sample size, time of follow-up, as well as changes in intermediate outcomes, for example, housing condition. This approach to visually summarising complex data can aid the reviewer in cross-study analysis and improve accessibility and transparency of the narrative synthesis where standardised effect sizes are not available. Copyright © 2012 John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1071" xmlns="http://purl.org/rss/1.0/"><title>Systematic Reviews to Support Evidence-based Medicine (2nd edition) by Khalid Khan, Regina Kunz, Jos Kleijnen and Gerd Antes: A Review</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1071</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Systematic Reviews to Support Evidence-based Medicine (2nd edition) by Khalid Khan, Regina Kunz, Jos Kleijnen and Gerd Antes: A Review</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Blair T. Johnson, Robert E. Low, Jessica M. LaCroix</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-07T10:55:42.017573-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/jrsm.1071</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/jrsm.1071</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fjrsm.1071</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Book Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">102</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">108</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>In many scientific disciplines, systematic reviews and meta-analyses are increasingly indispensable as summaries of the evidence in relation to a particular phenomenon, making it ever more important for scientists to know how best to review evidence. Khan, Kunz, Kleijnen, and Antes's <em>Systematic Reviews to Support Evidence-Based Medicine</em> (2nd edition, 2011, CRC Press, ISBN-13: 9781853157943) provides a fine, brief introduction to the subject, in particular for those in medicine and public health fields. Our review details strengths of this book, such as its conciseness and clarity and its close match to current conventions in systematic reviewing. We also discuss nuances of the subject that might augment a future edition or lead readers to other resources. In doing so, these discussions also address how present practices in systematic reviewing might improve. Copyright © 2013 John Wiley &amp; Sons, Ltd.</p></div>]]></content:encoded><description>
In many scientific disciplines, systematic reviews and meta-analyses are increasingly indispensable as summaries of the evidence in relation to a particular phenomenon, making it ever more important for scientists to know how best to review evidence. Khan, Kunz, Kleijnen, and Antes's Systematic Reviews to Support Evidence-Based Medicine (2nd edition, 2011, CRC Press, ISBN-13: 9781853157943) provides a fine, brief introduction to the subject, in particular for those in medicine and public health fields. Our review details strengths of this book, such as its conciseness and clarity and its close match to current conventions in systematic reviewing. We also discuss nuances of the subject that might augment a future edition or lead readers to other resources. In doing so, these discussions also address how present practices in systematic reviewing might improve. Copyright © 2013 John Wiley &amp; Sons, Ltd.</description></item></rdf:RDF>